Clinical Trial Update: A Study to Evaluate the Respiratory Safety of Lemborexant in Adult and Elderly Participants With Moderate to Severe Obstructive Sleep Apnea, and in Adult and Elderly Participants With Moderate to Severe Chronic Obstructive Pulmonary Disease [Phase 1]

View source ↗

Summary

Phase 1 study assessing respiratory safety of lemborexant in adults with obstructive sleep apnea and in adults with chronic obstructive pulmonary disease; compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Obstructive Sleep Apnea

Drugs mentioned

• Lemborexant (lemborexant)

Snippet

Sponsor: Eisai Inc. | Conditions: Sleep Apnea, Obstructive, Pulmonary Disease, Chronic Obstructive | Phase 1 | Status: COMPLETED | Results posted: 2023-10-10